GlassScriptPhysician profile
Miles Birmingham
NPI 1164703922
$88,681.14
in general payments reported to CMS, 2019-2025
9 companies · $646 in 2025
The $646 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $12K · 2021: $36K · 2022: $752 · 2023: $1,465 · 2024: $636 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,747.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $80,331.14 | 2019-2025 | Persona, Rosa, Arcos |
| Medical Device Business Services, INC. | $6,405.04 | 2019 | |
| Stryker Corporation | $1,186.90 | 2019-2025 | T2 Alpha, T2, Variax |
| Depuy Synthes Sales INC. | $480.09 | 2019-2023 | Attune, Actis, Pinnacle |
| Globus Medical, INC. | $75.63 | 2025 | Excelsius Gps |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.47 | 2020 | |
| Fortis Surgical, LLC | $68.56 | 2023 | |
| Ethicon US, LLC | $36.31 | 2024 | Vistaseal, Ethicon |
| Medacta USA, INC. | $25.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Birmingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.